+152.4%
MRNA vs VSH
+18.3%
+134.1%
-86.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 3y.
| Period | Portfolio | VSH | Excess | Alpha |
|---|---|---|---|---|
| 1D | +1.3% | -0.6% | +1.8% | +1.4% |
| 7D | -13.8% | -9.9% | -4.0% | -11.4% |
| 30D | -17.7% | -12.3% | -5.3% | -15.0% |
| 3M | +14.3% | -21.4% | +35.7% | +19.9% |
| 6M | +336.0% | -32.0% | +368.0% | +336.8% |
| YTD | +575.9% | +74.7% | +501.2% | +307.3% |
| 1Y | +724.4% | +107.3% | +617.1% | +355.3% |
| All | +152.4% | +18.3% | +134.1% | +97.0% |
Cumulative growth
Daily Returns
Daily percentage return beside VSH.
Daily Out/Under-Performance
Portfolio return minus VSH return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × VSH return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 3y: compounded portfolio wealth divided by compounded VSH wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
3y analysis · Full analysis span regression · 6 months rolling